Global Human Growth Hormone Market to Reach US$ 10.9 Billion by 2032, Accelerated by Growing Prevalence of Turner Syndrome

March 30, 2023 | Healthcare

As per the latest report by IMARC Group, titled "Human Growth Hormone Market Report by Application (Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS), Small for Gestational Age, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), Route of Administration (Intravenous, Intramuscular, Subcutaneous, Oral), and Region 2024-2032," the global human growth hormone market size reached US$ 5.7 Billion in 2023. Human Growth Hormone (HGH) is a naturally occurring peptide hormone that is produced by the pituitary gland. It is responsible for regulating various bodily functions, including growth, cell regeneration, and metabolic processes. It plays a crucial role in the overall development of the body, including bone and muscle growth, regulation of body fluids, and fat metabolism. Additionally, it helps regulate the breakdown of fats in the body, leading to increased energy levels and weight loss. It improves overall physical performance, including increased muscle mass, improved endurance, and faster recovery from injuries. HGH deficiency can lead to several health risks, including increased fat accumulation and a higher likelihood of developing certain diseases. In contrast, higher levels of HGH can result in various medical conditions, such as gigantism in children, acromegaly in adults, and muscle-wasting disease.

Global Human Growth Hormone Market Trends:

One of the primary drivers of the global human growth hormone market is the increasing prevalence of Turner syndrome. Moreover, the growing health consciousness and awareness among people regarding preventive measures against endocrine disorders are providing an impetus to the market growth. Furthermore, the rising use of medically synthesized HGH to treat various disorders caused by growth hormone deficiency and the surging use of HGH as performance enhancers by bodybuilders are accelerating the market growth. In line with this, key manufacturers are investing in advanced technology to innovate and improve their product offerings, which, in turn, is boosting the market growth. Apart from this, the development of recombinant human growth hormone (rHGH) by key players and burgeoning investments in research and development (R&D) activities are propelling the market growth. Looking forward, the market value is projected to reach US$ 10.9 Billion by 2032, expanding at a CAGR of 7.2% during 2024-2032.

Market Summary:

Based on application, the market is segmented into growth hormone (GH) deficiency (adult and pediatric GH deficiency), turner syndrome, idiopathic short stature (ISS), Prader Willi syndrome (PWS), small for gestational age, and others.
By distribution channel, the market is classified into hospital, retail, online, and other pharmacies.
On the basis of route of administration, the market is divided into intravenous, intramuscular, subcutaneous, and oral.
Based on region, the market has been segmented into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
The competitive landscape of the market has also been examined, with some of the key players being Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc., Ipsen, Merck KGaA, Novartis AG, Novo Nordisk, Pfizer Inc., Sandoz, etc.

Report Scope:

Report Features	Details
Base Year of the Analysis	2023
Historical Period	2018-2023
Forecast Period	2024-2032
Units	US$ Billion
Segment Coverage	Application, Distribution Channel, Route of Administration, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc., Ipsen, Merck KGaA, Novartis AG, Novo Nordisk, Pfizer Inc. and Sandoz
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 3899 Five User License: US$ 4899 Corporate License: US$ 5899
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Human Growth Hormone Market to Reach US$ 10.9 Billion by 2032, Accelerated by Growing Prevalence of Turner Syndrome

Purchase options

Single User License ~~$3899~~ $2999
Five User License ~~$4899~~ $3999
Corporate User License ~~$5899~~ $4999

Inquire Before Buying

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.